Skip to main content
. 2017 Nov 14;66(9):1427–1434. doi: 10.1093/cid/cix1012

Figure 1.

Figure 1.

Patient inclusion schema. Thirty-two of 268 chronic granulomatous disease (CGD) patients were eligible for analysis based on the criteria of (1) having a history of CGD liver involvement and (2) having complete, uninterrupted follow-up of their CGD liver care available within National Institutes of Health medical records. Abbreviations: BMT, bone marrow transplant; CGD, chronic granulomatous disease; CM, high-dose corticosteroid management; IR, interventional radiology; NIH, National Institutes of Health; OS, open surgery.